載入...
GLP-1 receptor agonists: an updated review of head-to-head clinical studies
Glucagon-like peptide-1 receptor agonists (GLP-1 RA) are attractive options for the treatment of type 2 diabetes (T2D) because they effectively lower A1C and weight while having a low risk of hypoglycemia. Some also have documented cardiovascular benefit. The GLP-1 RA class has grown in the last dec...
Na minha lista:
| 發表在: | Ther Adv Endocrinol Metab |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
SAGE Publications
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7953228/ https://ncbi.nlm.nih.gov/pubmed/33767808 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2042018821997320 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|